The Juvent Difference
Experience the benefits of SAFE whole body vibration
Walking barefoot used to send a mechanical signal up through the skeleton with every step. Bone responds by staying dense enough to take the next one.
Modern shoes changed that. Cushioned soles protect joints and absorb the very signal your bones rely on. So walking today, however much of it you do, isn't delivering what it used to.
Some people notice it as their bone density quietly declining. Some as joints that ache more. Some as circulation that's slower, or longer recovery. Different starting points. Same missing signal.
The Juvent Micro-Impact Platform® puts that signal back, calibrated to your body, at 32 to 37 Hz, every time you step on.
The Platform interacts with the person standing on it rather than running as an uncontrolled shaker. Juvent's technological heritage was never about maximizing acceleration or displacement. It's about delivering a controlled, resonant mechanical signal to a biological system capable of sensing extremely small physical inputs.
What Actually Happens When You Step On
A movement sensor reads your body composition and hydration; no dial, no setting, nothing for you to get wrong. Then it delivers a precise, low-magnitude signal at your own resonant frequency, the same process your cells have always used to convert physical force into a biological one.
Two minutes, and you'll see exactly what that looks like in practice.
A Cardiologist's Take on Micro-Impact Technology
Dr. Steven Gundry sat down with Juvent President Peter Simonson to talk through the mechanism, the research, and how a company built by a bone-growth-stimulation engineer ended up making the instrument you're looking at.
Watch Peter Simonson's RAADfest Presentation
Peter Simonson is Juvent's President and world-renowned medical device engineer.
Whitepapers
Clinical Benefits of Juvent's Micro-Impact Platform
This whitepaper highlights the clinical benefits of the Juvent Micro-Impact Platform®, showcasing its proven ability to enhance bone health, improve mobility, and support recovery through safe, non-invasive micro-impact therapy. Backed by extensive research, it’s your guide to understanding the transformative health impacts of Juvent.
Differentiating Human Health Benefits: Micro-Impact vs. Whole Body Vibration
This whitepaper compares Juvent's Micro-Impact Therapy with traditional whole-body vibration (WBV) platforms, highlighting its superior safety, precision, and effectiveness. Backed by clinical research, it demonstrates how Juvent delivers targeted benefits for bone health, mobility, and recovery without the risks associated with WBV.
Human Health Benefits of Low Magnitude Mechanical Stimulation (LMMS)
This whitepaper explores the science and clinical evidence behind Low-Magnitude Mechanical Signals (LMMS) and their profound impact on human health. It highlights how Juvent’s Micro-Impact Platform® harnesses LMMS to improve bone density, enhance mobility, and support overall well-being, offering a safe, non-invasive approach to long-term health benefits.
Juvent's Micro-Impact Platform for Increasing Bone Mineral Density in Pediatric Cancer Survivors
This whitepaper examines the role of Juvent's Micro-Impact Platform® in supporting cancer survivors. It highlights how Micro-Impact Therapy can help mitigate the effects of bone loss, improve mobility, and enhance overall quality of life following treatment. Backed by clinical research, the paper underscores Juvent’s safe and effective approach to addressing the unique health challenges faced by cancer survivors.
Juvent's Mission
Juvent develops research-grounded technology for musculoskeletal health. The Micro-Impact Platform® applies low-magnitude mechanical stimulation to support bone health, joint comfort, and lymphatic function.
The mechanical equivalent of a deficiency correction, not a workout. We call it a vitakin: what a vitamin does for what you eat, this does for what your skeleton isn't getting enough of anymore. The Vitamin of Exercise™.
Juvent's History
Electricity
Ryaby founded Electro-Biology, Inc.
Ryaby founded Electro-Biology, Inc. (EBI), and in 1976 filed a patent with physicist Arthur Pilla on changing how cells behave by changing the electrical environment around them. The FDA approved the EBI Bone Healing System in 1979 for fracture nonunions and failed fusions.
Sound
Electromagnetic to acoustic
At Exogen, the signal changed from electromagnetic to acoustic. Ryaby was named as an inventor on multiple patents for treating bone with low-intensity pulsed ultrasound. Smith & Nephew acquired the company in 1999.
Mechanics
The technology is proven
The last question was the most fundamental: could bone respond to mechanical signals far smaller than those produced by exercise?
In 2004, a prospective, randomized, double-blind, placebo-controlled trial in the Journal of Bone and Mineral Research reported a 3.35% relative increase in spinal bone mineral density and a 2.17% increase in the femur among women who used it consistently, compared with placebo. Ryaby was an author.
That trial is the one this entire category still rests on. He assembled a team from his bone-growth-stimulation years and built the instrument. That became Juvent. He passed away in December 2004.
A career in bone science that happened to end in a consumer instrument.
Not the other way around.
A New Beginning
Peter and Rush Simonson have led Juvent since 2011.
Peter Simonson, President of Juvent, is a Georgia Tech mechanical engineer who helped invent Medtronic's 3D spinal fixation system and was awarded Medtronic's Global Technical Contributor of the Year in 1999. Spinal fixation is an unusually demanding problem: an implant has to hold the spine stable enough for the bone to fuse within a moving, loaded, three-dimensional anatomy. It isn't a question of making something stronger. It's a question of how mechanical force, implant behavior, and biological healing interact, which is the same question Juvent asks from the other direction.
Rush Simonson represented Medtronic in over 1,000 spinal and neurological surgeries and invented the first posterolateral lumbar artificial-disc system. He later became the founding CEO of Cytonics, a proteomics company that identified the protein complex behind joint and back pain; that discovery became a monoclonal antibody now in FDA clinical trials. His work since has focused on a systems view of human health. The premise that the body holds hundreds of regenerative mechanisms that are routinely overlooked.
Engineers and clinicians, not marketers.
Frequently Asked Questions
What is low-magnitude mechanical stimulation?
The category that most vibration equipment doesn't belong to. Small, high-frequency mechanical signals delivered through the feet, under 1g, versus the higher magnitudes most vibration plates run at. Magnitude decides where the energy goes: high magnitude, and muscle braces and absorbs most of it before it ever reaches bone. Low magnitude, and more of it gets through.
Was Juvent developed by NASA?
No. NASA funded the underlying research because bone loss in microgravity was a real problem for astronauts, and that funding shaped the scientific literature on which this instrument is built. It didn't fund Juvent, and NASA has never used, evaluated, or endorsed the Platform. We keep that distinction exact on purpose.
Where can I read the individual studies?
Right here. Every whitepaper above cites its primary sources and is available for download as a PDF; no form, no email required. The peer-reviewed papers themselves are indexed in PubMed under low-magnitude mechanical stimulation, low-intensity vibration, and mechanotransduction, if you'd rather go straight to the source.
Who actually built this?
Jack Ryaby, an electrical engineer and medical-device pioneer, not just another entrepreneur who found a device to sell. He spent nearly five decades studying bone growth stimulation and was a named author of the 2004 clinical trial on which this category's mechanism rests.
He founded Electro-Biology, Inc. in the 1970s, where the FDA approved the EBI Bone Healing System in 1979 for fracture nonunions. He moved from electrical signals to ultrasound at Exogen, which Smith & Nephew acquired in 1999, and finally to mechanical signals at Juvent. Three different kinds of signal, one question: how small can a physical input be and still change bone biology?
This came out of the medical device field. It was never a fitness idea that borrowed some science to sound credible.
